1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Genetic Metabolic Diseases Advisory Committee
  6. Genetic Metabolic Diseases Advisory Committee Roster
  1. Genetic Metabolic Diseases Advisory Committee

Genetic Metabolic Diseases Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies = 3
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance.

Chairperson
Vacant

Designated Federal Officer
Jessica Seo, PharmD, MPH
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: GeMDAC@fda.hhs.gov

+Elizabeth M. Alessi, MTOPRA
Expertise: Rare Disease Drug Development, Regulatory Affairs
Term: 06/28/2024 to 10/31/2027
Vice President
Head of Regulatory Affairs, Medical Writing and Pharmacovigilance
Inozyme Pharma, Inc.
321 Summer Street, Suite 400
Boston, Massachusetts 02210

Gerard T. Berry, MD
Expertise: Biochemical Genetics
Term: 7/1/2024 – 6/30/2026
Professor of Pediatrics
Harvard Medical School
Medical Staff
Boston Children’s Hospital
3 Blackfan Circle, CLS Building
Molecular Genetics Core 19 030.19
Boston, Massachusetts 02115

*Sarah Chamberlin
Expertise: Inborn Errors of Metabolism Community Development, Care, Research, and Advocacy
Term: 8/1/2024 – 6/30/2028
Founder and Executive Director, flok Health
PO Box 43552
Montclair, New Jersey 07043

Wendy K. Chung, MD, PhD
Expertise: Medical Genetics
Term: 7/1/2024 – 6/30/2026
Professor
Harvard Medical School
Chief, Department of Pediatrics
Boston Children’s Hospital
300 Longwood Avenue
Boston, Massachusetts 02215

**Bradley J. Glasscock, PharmD
Expertise: Rare Disease Drug Development, Regulatory Affairs
Term: 6/28/2024 – 10/31/2027
Senior Vice President
Head of Global Regulatory Affairs
BioMarin Pharmaceutical Inc.
105 Digital Drive
Novato, California 94949

Priya S. Kishnani, MD
Expertise: Clinical Biochemical Genetics and Clinical Genetics and Genomics
Term: 7/1/2024 – 6/30/2026
Professor of Pediatrics
Duke University Medical Center
GSRB1 Building, 4th Floor, Room 4010
Box 103856, DUMC
905 South LaSalle Street
Durham, North Carolina 27710

Jean-Baptiste Le Pichon, MD, PhD, FAAP
Expertise: Pediatric Neurology
Term: 01/28/2025 – 06/30/2027
Professor
University of Missouri-Kansas City
2401 Gillham Rd,
Kansas City, MO 64108

Jonathan W. Mink, MD PhD
Expertise: Child Neurology and Movement Disorders
Term: 8/1/2024 – 6/30/2026
Private Consultant
Pittsford, New York 14534

 

* Consumer Representative 
** Industry Representative (non-voting)
+ Alternate Industry Representative

Back to Top